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Abstract
Background: To present a diagnostic evaluation and treatment strategy for serous
adenocarcinoma of the ovary discovered during an in vitro fertilisation (IVF) sequence, and report
on reproductive outcome after tumour resection and embryo transfer.
Case presentation: Cycle monitoring in IVF identified an abnormal ovarian lesion which was
subjected to ultrasound-guided needle aspiration. Cytology suggested malignancy, and unilateral
oophorectomy was performed after formal staging. After surgery, the patient underwent an
anonymous donor oocyte IVF cycle which established a viable twin intrauterine pregnancy. No
recurrence of cancer has been detected in the >72 month follow-up interval; mother and twin
daughters continue to do well.
Conclusion: Suspicious adnexal structures noted during controlled ovarian hyperstimulation for
IVF warrant assessment, and this report confirms the role of aspiration cytology in such cases. If
uterine conservation is possible, successful livebirth can be achieved from IVF if donor oocyes are
utilised, as described here.
Background
Malignant ovarian neoplasms are uncommonly encoun-
tered during in vitro fertilisation (IVF). While response to
gonadotropin treatment during fertility treatment is typi-
cally confined to assessment of follicular dimensions cor-
related with serum oestradiol levels, any abnormal
ovarian morphology observed in this context should
prompt careful evaluation and prompt referral to a gynae-
cologic oncologist. This is the first reported case in Europe
of aspiration cytology used to identify ovarian serous ade-
nocarcinoma during IVF, and highlights the role of this
investigative approach for patients undergoing advanced
reproductive treatments.
Case presentation
A healthy 28 year-old nulligravida with polycystic ovary
syndrome and no family history of breast or ovarian can-
cer was referred with her husband for reproductive endo-
crinology consultation. He was 31 and had a prior semen
analysis suggesting asthenozoospermia (motility <40%).
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Hysteroscopy and laparoscopic ovarian drilling had been
performed about six months before beginning fertility
treatment. Bilateral tubal patency was confirmed and both
ovaries appeared grossly unremarkable. Screening labora-
tory tests for both partners were normal and repeat semen
analysis here found sperm concentration to be 100 M/ml,
motility 60% and 35% abnormal forms (1992 WHO cri-
teria). Based on these findings, the couple elected to
undergo intrauterine insemination following ovulation
induction with clomiphene citrate. After no pregnancy
was achieved after three cycles, a simple 4 cm right ovarian
cyst was noted and further ovulation induction was
deferred until this lesion regressed. The cyst was essen-
tially unchanged two months later, and serum CA-125
was 36.2 u/ml (reference range <35 u/ml), although the
borderline elevation was thought to be secondary to
recent exposure to fertility agents. By this time, the couple
had elected to pursue IVF and, in anticipation of this, the
cyst was decompressed by ultrasound-guided transvaginal
needle drainage. While this cyst fluid was not specifically
analysed, the ovaries now appeared grossly normal and an
uneventful IVF cycle commenced. Seventeen oocytes were
retrieved, and careful assessment of the right ovary identi-
fied a septated 3.8 cm cyst (Figure 1) which was aspirated
separately from follicular fluid and collected oocytes. The
structure was mapped to a similar location where the pre-
vious needle puncture and drainage had occurred. This
time, the ovarian cyst fluid was submitted for formal cyto-
logic evaluation. The patient had an uncomplicated day-
three embryo transfer (n = 2), and there were three blast-
ocysts available for subsequent cryopreservation.
The cytology data were returned five days after embryo
transfer, and was consistent with borderline or well-differ-
entiated serous adenocarcinoma. The patient was coun-
selled and gynaecologic oncology referral was initiated.
The pregnancy test from IVF was negative and 14 d after
receiving the cytologist's report, the patient underwent
laparotomy for unilateral right oophorectomy, left ovar-
ian biopsy, omentectomy, appendectomy, and pelvic/
para-aortic lymph node biopsy. Intraoperative pelvic
washings were submitted for cytology and were negative.
Staging showed benign tissue throughout, although a
small focus of similar cancer was identified in the left
ovary; at the patient's request pre-operatively this ovary
remained in situ. The diagnosis of Stage IB ovarian serous
adenocarcinoma of low malignant potential (Figure 2)
was made, and the patient had an unremarkable post-sur-
gical recovery.
The patient had monthly assessments by the gynaecologic
oncologist who mandated frequent follow-up visits while
ovulation induction was temporarily interrupted. This
was coordinated with our IVF clinic, and numerous ultra-
sound studies were performed on her left ovary. The left
ovary was removed by laparotomy 13 months after the
right ovary and no additional abnormal cells were identi-
fied. Eight months later, the patient's frozen embryos were
thawed and transferred but the pregnancy test was nega-
tive 14 d later. An anonymous donor oocyte IVF cycle
commenced 16 months later and this resulted in a two-
Transvaginal ultrasound image of septated right ovarian cyst in IVF, which reappeared after puncture performed prior togonadotropin therapyFigure 1
Transvaginal ultrasound image of septated right 
ovarian cyst in IVF, which reappeared after puncture 
performed prior to gonadotropin therapy. Aspirated 
fluid was consistent with borderline vs. well-differentiated 
ovarian serous adenocarcinoma.
Ovarian serous adenocarcinoma with finger-like papillae with fibrov scular core covered by multilayered cuboidal/colum-na  epithe iumFigure 2
Ovarian serous adenocarcinoma with finger-like 
papillae with fibrovascular core covered by multilay-
ered cuboidal/columnar epithelium. Haematoxylin and 
eosin, ×400.
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blastocyst transfer, following oncology clearance. A posi-
tive pregnancy test was noted 12 d after transfer and a via-
ble twin intrauterine pregnancy was identified on
transvaginal ultrasound on day 55. Her obstetrical course
was uncomplicated until 31 weeks' gestation, when
extreme oedema developed. Although she was normoten-
sive and albuminuria was absent, moderately severe
abdominal pain supervened and the patient was delivered
by Caesarean at 34 1/2 weeks' gestation. During surgery,
dense adherence of small bowel to the anterior uterine
wall was noted and was regarded as the cause of the
abdominal pain which resolved postoperatively. The
patient remains cancer free for >72 months and her twin
daughters (now age 4) continue to do well.
Discussion
Frequent ovarian monitoring by transvaginal ultrasound
is central to IVF patient evaluation, and this surveillance
can occasionally result in the discovery of occult, subclin-
ical cysts that would otherwise go undetected [1]. Even
when complex ovarian cysts are incidentally noted at
baseline ultrasound, the necessity of aspirating such
lesions before IVF has been questioned. Indeed, an analy-
sis of over 200 IVF patient cycles concluded that baseline
cysts do not negatively affect reproductive outcome [2].
Endometriotic cysts and dermoids account for many of
these cysts, and only two prior cases of ovarian cancer
related to IVF – both from USA – appear in the literature
[1,3].
Data on aspiration cytology of ovarian cysts developing in
patients undergoing IVF treatment was considered rare a
decade ago [3], and there has been little published on the
topic since. The high false negative rate for nonfollicular
lesions has limited the diagnostic value of aspiration
cytology for many ovarian cysts [4] and information pro-
vided by ovarian cyst aspiration has been shown to corre-
late poorly with histology from tissue obtained at surgery
[5]. Indeed, a four-year series comparing ovarian cyst
cytology with histologic findings based on cases collected
at a single centre reported 20% of cytology specimens as
non-diagnostic [6]. Interestingly, aspiration cytology
failed to determine the exact underlying nature of ovarian
cysts in >50% of lesions when applied specifically to IVF
patients, and an ovarian serous cystadenocarcinoma was
the only malignancy identified [3]. Others have found
aspiration cytology to be an accurate predictor of malig-
nancy in cystic ovarian lesions, but have discouraged reli-
ance on aspiration cytology results alone [7].
This case is only the third published report of ovarian can-
cer identified during IVF, and is the first to offer long-term
follow up. However, several aspects of clinical manage-
ment could have been different and warrant comment.
First, cytologic examination of the initial ovarian cyst fluid
would have suggested malignancy about a month earlier
and would have justified abandonment of the planned
IVF cycle. We subsequently modified institutional policy
to mandate external cytology review for any ovarian cyst
aspirates obtained here. Second, bilateral oophorectomy
could have been performed during formal staging. This
would have obviated the need for a second surgery for
removal of the contralateral ovary, and arguably could
have hastened the patients' enlistment into a donor
oocyte programme for definitive fertility treatment. The
possibility of bilateral oophorectomy was presented
before the first laparotomy, and the patient was thor-
oughly counselled about potential malignant spread if
this was not done. We also discussed the potential for
malignant spread secondary to intraperitoneal spillage
during cyst puncture. Even though a frozen embryo trans-
fer remained a possibility, the patient did not wish to have
both ovaries immediately removed. The tailored, multi-
stage surgical approach described here was only possible
with co-management by gynaecologic oncology and
should not be undertaken without such support.
In summary, although aspiration cytology of ovarian cysts
sometimes presents an unclear picture [8] it can help
identify patients for whom oncology consultation is
immediately indicated. We therefore support formal cyto-
logic assessment of any suspicious complex ovarian lesion
despite the recognised limitations of this approach.
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